{"id":122,"date":"2026-02-24T17:44:44","date_gmt":"2026-02-24T17:44:44","guid":{"rendered":"http:\/\/test.local\/?page_id=122"},"modified":"2026-05-11T11:43:37","modified_gmt":"2026-05-11T10:43:37","slug":"investors","status":"publish","type":"page","link":"https:\/\/lucidpharma3ds.com\/?page_id=122","title":{"rendered":"Investors"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"122\" class=\"elementor elementor-122\">\n\t\t\t\t<div class=\"elementor-element elementor-element-456f59df e-con-full animated-slow e-flex elementor-invisible e-con e-parent\" data-id=\"456f59df\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;animation&quot;:&quot;fadeInDown&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-5a4fe6e4 e-con-full e-flex e-con e-child\" data-id=\"5a4fe6e4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-745830d7 elementor-widget__width-initial elementor-widget-mobile__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"745830d7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=19\">HOME<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-75f15bf3 e-con-full e-flex e-con e-child\" data-id=\"75f15bf3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3ede054e elementor-widget__width-initial elementor-widget-mobile__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"3ede054e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=104\">RADIANZ MDE<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4af03d65 e-con-full e-flex e-con e-child\" data-id=\"4af03d65\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8553569 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"8553569\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=257\">ABOUT<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3b67ec7d e-con-full e-flex e-con e-child\" data-id=\"3b67ec7d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7bbef22d elementor-widget elementor-widget-text-editor\" data-id=\"7bbef22d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=109\">PUBLICATIONS<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-743b607e e-con-full e-flex e-con e-child\" data-id=\"743b607e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-59bca427 elementor-widget elementor-widget-text-editor\" data-id=\"59bca427\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=122\">INVESTORS<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7c1c88eb e-con-full e-flex e-con e-child\" data-id=\"7c1c88eb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-23f7fcd5 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"23f7fcd5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=129\"><span style=\"font-weight: normal;\">CONTACT<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-132e3fae e-con-full animated-slow e-flex elementor-invisible e-con e-parent\" data-id=\"132e3fae\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-15db747b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"15db747b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-73f5f8ad e-con-full animated-slow e-flex elementor-invisible e-con e-parent\" data-id=\"73f5f8ad\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2cfaca89 elementor-widget__width-inherit elementor-view-default elementor-position-block-start elementor-mobile-position-block-start elementor-widget elementor-widget-icon-box\" data-id=\"2cfaca89\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-box.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-box-wrapper\">\n\n\t\t\t\t\t\t<div class=\"elementor-icon-box-icon\">\n\t\t\t\t<span  class=\"elementor-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-angle-double-right\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M224.3 273l-136 136c-9.4 9.4-24.6 9.4-33.9 0l-22.6-22.6c-9.4-9.4-9.4-24.6 0-33.9l96.4-96.4-96.4-96.4c-9.4-9.4-9.4-24.6 0-33.9L54.3 103c9.4-9.4 24.6-9.4 33.9 0l136 136c9.5 9.4 9.5 24.6.1 34zm192-34l-136-136c-9.4-9.4-24.6-9.4-33.9 0l-22.6 22.6c-9.4 9.4-9.4 24.6 0 33.9l96.4 96.4-96.4 96.4c-9.4 9.4-9.4 24.6 0 33.9l22.6 22.6c9.4 9.4 24.6 9.4 33.9 0l136-136c9.4-9.2 9.4-24.4 0-33.8z\"><\/path><\/svg>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t<div class=\"elementor-icon-box-content\">\n\n\t\t\t\t\t\t\t\t\t<h4 class=\"elementor-icon-box-title\">\n\t\t\t\t\t\t<span  >\n\t\t\t\t\t\t\tInvestors\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<p class=\"elementor-icon-box-description\">\n\t\t\t\t\t\tStrategic &amp; Partnering Opportunities<br>\n<br><span style=\"font-weight: normal\">Lucid Pharma 3DS is focused on the application of medicinal chemistry and molecular design technologies to support the generation of differentiated pre-clinical therapeutic opportunities.<\/span><br><span style=\"font-weight: normal\">\n<\/span><br><span style=\"font-weight: normal\">Alongside external discovery support activities, Lucid Pharma 3DS is advancing internally generated molecular design programmes in areas of significant unmet medical and commercial interest.<\/span><br><span style=\"font-weight: normal\">\n<\/span><br><span style=\"font-weight: normal\">The company is currently exploring strategic discussions, scientific collaborations and early-stage partnering opportunities relating to selected internally developed programmes.<\/span><br><br><br>GLP-1 Receptor Agonist Programme<br>\n<br><span style=\"font-weight: normal\">Lucid Pharma 3DS is currently developing a differentiated GLP-1 receptor agonist fast-follower programme focused on the identification of novel small molecule opportunities within the rapidly evolving metabolic disease landscape.<\/span><br><span style=\"font-weight: normal\">\n<\/span><br><span style=\"font-weight: normal\">Current activities are focused on:<\/span><br><span style=\"font-weight: 400;white-space: normal\">\u2022&nbsp;<\/span><span style=\"font-weight: normal\">molecular design and optimisation strategy<\/span><br><span style=\"font-weight: 400;white-space: normal\">\u2022&nbsp;<\/span><span style=\"font-weight: normal\">evaluation of intellectual property positioning<\/span><br><span style=\"font-weight: 400;white-space: normal\">\u2022&nbsp;<\/span><span style=\"font-weight: normal\">target candidate prioritisation<\/span><br><span style=\"font-weight: 400;white-space: normal\">\u2022&nbsp;<\/span><span style=\"font-weight: normal\">development planning toward early experimental validation<\/span><br><span style=\"font-weight: normal\">\n<\/span><br><span style=\"font-weight: normal\">The programme remains at an early pre-clinical stage and Lucid Pharma 3DS is actively exploring opportunities for strategic collaboration, scientific partnership and investment support to accelerate progression toward synthesis and biological evaluation.<\/span><br><br>Programme Rationale<br><br>\n<span style=\"font-weight: normal\">Despite significant advances in incretin-based therapeutics, substantial opportunities remain for differentiated approaches addressing manufacturability, molecular properties, tolerability, route of administration, and broader metabolic disease applications.<br><br>\nLucid Pharma 3DS believes that focused molecular design strategies combined with practical medicinal chemistry expertise may provide opportunities to identify novel candidates capable of addressing selected limitations associated with current therapeutic approaches.<\/span><br><br>Lucid Pharma 3DS welcomes discussions with:<br>\n<span style=\"font-weight: normal\">\n<\/span><span style=\"font-weight: 400;white-space: normal\"><br>\u2022<\/span><span style=\"font-weight: normal\"> strategic investors<br>\n<\/span><span style=\"font-weight: 400;white-space: normal\">\u2022<\/span><span style=\"font-weight: normal\"> incubator and venture creation groups<br>\n<\/span><span style=\"font-weight: 400;white-space: normal\">\u2022<\/span><span style=\"font-weight: normal\"> translational research collaborators<br>\n<\/span><span style=\"font-weight: 400;white-space: normal\">\u2022<\/span><span style=\"font-weight: normal\"> contract research partners<br>\n<\/span><span style=\"font-weight: 400;white-space: normal\">\u2022<\/span><span style=\"font-weight: normal\"> organisations active in metabolic disease therapeutics development.<br><br>\n\nPlease contact us for additional information regarding current partnering discussions.<\/span>\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-260e9090 e-con-full e-flex e-con e-parent\" data-id=\"260e9090\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-62eea2ab elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"62eea2ab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-18919099 e-con-full e-flex e-con e-parent\" data-id=\"18919099\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-43e49558 e-con-full e-flex e-con e-child\" data-id=\"43e49558\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-629db63f elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"629db63f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=172\">PRIVACY POLICY<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-442240d9 e-con-full e-flex e-con e-child\" data-id=\"442240d9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-58114514 elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"58114514\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/lucidpharma3ds.com\/?page_id=172\">ACCESSIBILITY STATEMENT<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6b2b59a4 e-flex e-con-boxed e-con e-child\" data-id=\"6b2b59a4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-447687b3 elementor-widget elementor-widget-text-editor\" data-id=\"447687b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>(C) COPYRIGHT 2026. ALL RIGHTS RESVERVED<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>HOME RADIANZ MDE ABOUT PUBLICATIONS INVESTORS CONTACT Investors Strategic &amp; Partnering Opportunities Lucid Pharma 3DS is focused on the application of medicinal chemistry and molecular design technologies to support the generation of differentiated pre-clinical therapeutic opportunities. Alongside external discovery support activities, Lucid Pharma 3DS is advancing internally generated molecular design programmes in areas of significant [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-122","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"_links":{"self":[{"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/pages\/122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=122"}],"version-history":[{"count":46,"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/pages\/122\/revisions"}],"predecessor-version":[{"id":436,"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=\/wp\/v2\/pages\/122\/revisions\/436"}],"wp:attachment":[{"href":"https:\/\/lucidpharma3ds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}